Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history
» SLTM's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2013

SLTM Guru Trades in Q2 2013

Jim Simons 217,700 sh (+26.08%)
John Keeley 10,000 sh (unchged)
Ruane Cunniff 2,386,937 sh (unchged)
» More
Q3 2013

SLTM Guru Trades in Q3 2013

John Keeley 10,000 sh (unchged)
Ruane Cunniff Sold Out
Jim Simons Sold Out
» More
Q4 2013

SLTM Guru Trades in Q4 2013

Jean-Marie Eveillard 350,000 sh (New)
Mario Gabelli 410,000 sh (New)
John Keeley 10,000 sh (unchged)
» More
Q1 2014

SLTM Guru Trades in Q1 2014

Jean-Marie Eveillard Sold Out
John Keeley Sold Out
Mario Gabelli Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with SLTM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Mario Gabelli 2014-03-31 Sold Out 0.01%$2.95 - $2.99 $ 2.92-2%0
John Keeley 2014-03-31 Sold Out $2.95 - $2.99 $ 2.92-2%0
Jean-Marie Eveillard 2014-03-31 Sold Out $2.95 - $2.99 $ 2.92-2%0
Mario Gabelli 2013-12-31 New Buy0.01%$1.76 - $2.99 $ 2.9235%410000
Jean-Marie Eveillard 2013-12-31 New Buy$1.76 - $2.99 $ 2.9235%350000
Ruane Cunniff 2013-09-30 Sold Out 0.04%$2.01 - $2.76 $ 2.9229%0
John Keeley 2012-06-30 New Buy$2.5 - $3.25 $ 2.922%10000
Ruane Cunniff 2011-12-31 New Buy0.07%$1.23 - $3.18 $ 2.9228%2386937
John Keeley 2011-09-30 Sold Out 0.0005%$1.23 - $2.8 $ 2.9254%0
George Soros 2011-09-30 Sold Out 0.0005%$1.23 - $2.8 $ 2.9254%0
George Soros 2011-06-30 New Buy$2.45 - $3.63 $ 2.92-5%11965
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history

Valuation & Return

vs
industry
vs
history

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:NZ5.Germany
Solta Medical, Inc. was incorporated in California on January 11, 1996 as Thermage, Inc. and reincorporated in Delaware on September 10, 2001. It designs, develops, manufactures and markets energy-based medical device systems for aesthetic applications. The Company markets its systems and treatment tips in the United States to physician practices primarily through a direct sales force and internationally in over 100 countries through both a network of distributors and direct sales force. Its customers consist mainly of dermatologists and plastic surgeons and its expanded customer base includes other specialties such as general and family practitioners, gynecologists, ophthalmologists and others. These systems are marketed under the brand names Fraxel and Thermage. It currently markets four Fraxel products: The re:store, re:store Dual, re:fine and re:pair. The Fraxel re:store, Fraxel re:store Dual and Fraxel re:fine laser platforms non-ablatively treat a range of applications that include wrinkles and fine lines, pigmentation, sun damage, uneven skin texture and melasma. The Company's Thermage systems consist of a radiofrequency (RF) generator with cooling capability, through the delivery of a coolant to protect the outer layer of the skin from over-heating, and a hand piece that, in conjunction with a treatment tip, regulates epidermis cooling and monitors treatment data. Its system includes a variety of single-use, disposable treatment tips that attach to the hand piece and are selected by physicians based on the procedure to be performed and the size of the area to be treated. The Company sells its Thermage and Fraxel systems to physicians in the United States primarily through a direct sales force of trained sales consultants. Its industry is subject to intense competition. It compete directly against laser and light-based skin rejuvenation products and procedures offered by companies such as Alma Laser, Cutera, Cynosure, Lumenis, Lutronic, Palomar Medical Technologies, Sciton and Syneron Medical. In addition, it compete against existing and emerging treatment alternatives such as cosmetic surgery, chemical peels, microdermabrasion, Botox, dermal fillers and collagen injections. The Company's Thermage and Fraxel systems are medical devices and are subject to extensive and rigorous regulation by the U.S. Food and Drug Administration (FDA), as well as other federal and state regulatory bodies in the United States and laws and regulations of foreign authorities in other countries.
» More Articles for SLTM

Headlines

Articles On GuruFocus.com
paul.lemmerman note on SLTM Dec 01 2010 
Solta Medical Inc (SLTM) COO Clint Carnell buys 20,000 Shares Jun 01 2009 
Solta Medical Inc Reports Operating Results (10-Q) May 06 2009 

More From Other Websites
SOLTA MEDICAL INC Files SEC form 8-K, Termination of a Material Definitive Agreement, Completion of... Jan 24 2014
Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Solta Medical, Inc. Jan 23 2014
Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Solta Medical, Inc. Jan 23 2014
Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Solta Medical, Inc. Jan 23 2014
Valeant Pharmaceuticals International, Inc. Completes Tender Offer for Solta Medical, Inc. Jan 23 2014
Valeant completes tender offer for Solta, Solta to no longer be listed on NASDAQ Jan 23 2014
Valeant Pharmaceuticals International, Inc. Completes Tender Offer for Solta Medical, Inc. Jan 23 2014
Valeant Pharmaceuticals International, Inc. Completes Tender Offer for Solta Medical, Inc. Jan 23 2014
Solta Medical, Inc. Stockholders Encouraged to Contact Securities Law Firm about Takeover Jan 17 2014
Valeant recieves antitrust cclearance for Solta Medical acquisition Jan 15 2014
Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced... Jan 15 2014
Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced... Jan 15 2014
Valeant Attains 52-Week High Jan 02 2014
Lifshitz Law Firm Announces Investigation of Coleman Cable, Inc., NuPathe Inc., Solta Medical, Inc.,... Dec 30 2013
Solta Medical Agrees To Be Acquired By Valeant, But Another Bid Might Emerge Dec 23 2013
Is This the Top for Solta Medical Inc. (SLTM)? Dec 20 2013
INVESTOR ALERT Levi & Korsinsky, LLP Announces Investigation of SOLTA MEDICAL, INC. and Its Board of... Dec 18 2013
Stocks Mixed Ahead Of Fed; ARM Clears Buy Point Dec 18 2013
Attention SLTM Shareholders: The Proposed Buyout of Solta Medical, Inc by Valeant Pharmaceuticals... Dec 17 2013

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide